日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia

FLT3-ITD 和获得性 13q 单亲二体性的克隆结构决定了急性髓系白血病的预后异质性和治疗脆弱性。

Lai, Anli; Liu, Wenbing; Mei, Yihan; Zhang, Qimin; Zhang, Junping; Tang, Kejing; Rao, Qing; Gu, Runxia; Feng, Sizhou; Wang, Ying; Wang, Min; Wei, Hui; Mi, Yingchang; Qiu, Shaowei; Wang, Jianxiang

Who is at risk? Clinical features and a predictive model for 30-day mortality in hematologic patients with enterococcal bloodstream infection

哪些人面临风险?血液病患者肠球菌血流感染的临床特征及30天死亡率预测模型

Yang, Nuobing; Zhen, Sisi; Zhang, Tingting; Fan, Yuping; Lin, Qingsong; Mi, Yingchang; Zheng, Yizhou; Qiu, Lugui; Zhang, Fengkui; Jiang, Erlie; Han, Mingzhe; Xiao, Zhijian; Wang, Jianxiang; Feng, Sizhou; Chen, Xin

Impact of Fusion Partners and Transplantation Benefit in Intensively Treated KMT2A-Rearranged Acute Myeloid Leukemia

融合伴侣和移植获益对接受强化治疗的KMT2A重排急性髓系白血病的影响

Shen, Heng; Chen, Jiayuan; Gong, Xiaoyuan; Zhou, Chunlin; Lin, Dong; Liu, Kaiqi; Gong, Benfa; Zhang, Guangji; Li, Yan; Liu, Yuntao; Qiu, Shaowei; Liu, Bingcheng; Wang, Ying; Mi, Yingchang; Fang, Qiuyun; Wang, Jianxiang; Wei, Hui

Efficacy and safety of mini-cvd combined with venetoclax and azacitidine in philadelphia chromosome-negative acute leukemia of ambiguous lineage: a single-center retrospective study

mini-CVD联合维奈托克和阿扎胞苷治疗费城染色体阴性、谱系不明的急性白血病的疗效和安全性:一项单中心回顾性研究

Li, Yan; Shang, Yue; Liu, Kaiqi; Liu, Yuntao; Lin, Dong; He, Jinsong; Li, Jiesi; Zeng, Yanping; Wei, Hui; Yan, Zhangsong; Mi, Yingchang

Dynamin2 mutations in newly diagnosed acute myeloid leukemia: clinical characteristics, and prognostic significance

新诊断急性髓系白血病中动力蛋白2突变:临床特征和预后意义

Luo, Kunpeng; Chen, Jiayuan; Wang, Wenting; Hui, Yan; Qiu, Shaowei; Liu, Bingcheng; Mi, Yingchang; Wang, Jianxiang; Wei, Hui

Clinical characteristics and therapeutic determinants of RUNX1::RUNX1T1 differ from those of CBFB::MYH11 acute myeloid leukemia

RUNX1::RUNX1T1 的临床特征和治疗决定因素与 CBFB::MYH11 急性髓系白血病不同。

Yang, Miao; Wang, Wenting; Zhang, Guangji; Qiu, Shaowei; Liu, Bingcheng; Mi, Yingchang; Wang, Ying; Wang, Jianxiang; Wei, Hui

Measurable residual disease recurrence as early warning of relapse in acute myeloid leukemia

可测量的残留病灶复发可作为急性髓系白血病复发的早期预警信号

Gong, Benfa; Yang, Miao; Qiu, Shaowei; Liu, Bingcheng; Wang, Ying; Mi, Yingchang; Wei, Hui; Wang, Jianxiang

Progression significance for low-level aberrant B-lymphoblasts in chronic myeloid leukaemia patients

慢性粒细胞白血病患者中低水平异常B淋巴母细胞的进展意义

Wang, Haoren; Wang, Huijun; Li, Yuanyuan; Zheng, Bin; Fang, Qiuyun; Li, Yan; Liu, Yuntao; Gu, Runxia; Wang, Ying; Mi, Yingchang; Liu, Bingcheng; Wei, Hui; Wang, Jianxiang

KMT2C/D mutations in newly diagnosed acute myeloid leukaemia: Clinical features, genetic co-occurrences and prognostic significance

新诊断急性髓系白血病中KMT2C/D突变:临床特征、基因共现及预后意义

Wang, Wenting; Yang, Miao; Zhang, Xue; Chen, Jiayuan; Qiu, Shaowei; Liu, Bingcheng; Mi, Yingchang; Wang, Jianxiang; Wei, Hui

Comprehensive omics-based classification system in adult patients with B-cell acute lymphoblastic leukemia

基于组学的成人B细胞急性淋巴细胞白血病分类系统

Song, Yang; Liu, Ting; Hao, Qishan; Fang, Qiuyun; Gong, Xiaoyuan; Li, Yan; Tian, Zheng; Wei, Hui; Wang, Min; Wang, Jianxiang; Cheng, Tao; Mi, Yingchang